Genetic Study of Families Affected by Paget's Disease of Bone (PAGET)

This study has been completed.
Sponsor:
Collaborators:
Novartis
Association Rhumatisme et Travail
Information provided by:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00747994
First received: September 5, 2008
Last updated: July 12, 2010
Last verified: July 2010
  Purpose

Paget's disease of bone is a frequent bone disorder which usually starts after the age of 40 and which is characterized by bone pain and deformities. Although often without any symptoms, this disease may have severe complications such as fissures, fractures, neurological compression, or deafness. In some cases, it is a genetic disorder transmitted with a dominant autosomal pattern of inheritance: one of the two parents carrying the disease transmits it to his offspring with a risk of 50% for each child. Since 2002, the first gene involved in Paget's disease of bone is known and 14 mutations of this gene have been published. A study confirmed that the presence of those mutations was associated with younger age of onset and more extensive disease. Thus, the knowledge of those genetic factors in the relatives of an affected individual allows the screening of the patients with a higher risk for complications, who may benefit from a medical follow up and earlier treatment, in order to avoid complications. Indeed, Paget's disease of bone may be treated efficiently by bisphosphonates.

This project aims at identifying and collecting over one year, 15 affected individuals affected by Paget's disease of bone and the relatives up to the second degree of relativeness (a total of 100 individuals is expected). The blood samples may be analysed in order to search for mutations of the previously known gene and/or to search for new mutations on new genes.


Condition
Paget's Disease of Bone

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Retrospective
Official Title: Genetic Study of Families Affected by Paget's Disease of Bone

Resource links provided by NLM:


Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • To identify new mutations or new haplotypes of mutations already identified, and/or to identify new mutations in new genes of Paget's disease of bone. [ Time Frame: 2007-2008 ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

collection of extracted DNA, RNA and serum samples and urinary samples


Enrollment: 83
Study Start Date: September 2007
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

15 patients affected by Paget's disease of bone and their relatives at the first or second degree of relativeness total of about 100 individuals

Criteria

Inclusion Criteria:

  • Patient aged over 18 years,
  • patient who underwent a clinical examination,
  • patient who gave its written consent,

    1. Each individual (index case) affected by Paget's disease of bone (with diagnosis confirmed by alkalies phosphatases analysis and/or imaging with bone scintigraphy and radiographies on the affected sites with a typical aspect of the disease), and :

      • At least one relative affected by Paget's disease of bone with confirmed diagnosis (see above),
      • Or an age at diagnosis < 55 years,
      • Or a polyostotic involvement with at least 4 affected bones,
      • Or the presence of a bone deformity at the time of the diagnosis.
    2. Each relative with established phenotype by imaging (bone scintigraphy and/or radiographies), at first or second degree of relativeness of an index case defined in (a).

Exclusion Criteria:

  • Index case with not confirmed Paget's disease of bone by biological and/or radiological examinations,
  • Index with confirmed Paget's disease but without relative with the same disease, with an age at diagnosis >55 years, with a number of affected bones <4, without any bone deformity at the time of the diagnosis
  • Healthy relatives of a Paget patient who refuse to undergo bone scintigraphy and bone radiographies.
  • Individuals < 18 years
  • Pregnant or breast
  • feeding woman-individual living ina sanitary or social establishment
  • individual under guardianship
  • individual in an emergency situation
  • individual unable to give his consent
  • incarcerated individual
  • patient not covered by healthcare institutions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00747994

Locations
France
CHU Lariboisière
Paris, Ile de France, France, 75010
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Novartis
Association Rhumatisme et Travail
Investigators
Study Director: Laetitia Michou, MD PhD CHU Lariboisière
  More Information

Publications:
Responsible Party: Yannick Vacher, Department Clinical Research of Developpement
ClinicalTrials.gov Identifier: NCT00747994     History of Changes
Other Study ID Numbers: P070203
Study First Received: September 5, 2008
Last Updated: July 12, 2010
Health Authority: France: Ministry of Health

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Paget's disease of bone
Relatives
Mutations screening
Haplotypes analysis
Linkage analysis
< 55 years
4 > or = WAFFECTED Bones
bone deformity

Additional relevant MeSH terms:
Osteitis Deformans
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on September 18, 2014